Role of the IRS-1 and/or -2 in the Pathogenesis of Insulin Resistance in Dahl Salt-Sensitive (S) Rats

Abstract

Insulin resistance is a common finding in hypertensive humans and animal models. The Dahl salt-sensitive (S) rat is an ideal model of genetically predetermined insulin resistance and salt-sensitive hypertension. Along the insulin signaling pathway, the insulin receptor substrates 1 and 2 (IRS-1 and-2) are important mediators of insulin signaling. IRS-1 and/or IRS-2 genetic variant(s) and/or enhanced serine phosphorylation correlate with insulin resistance. The present commentary was designed to highlight the significance of IRS-1 and/or-2 in the pathogenesis of insulin resistance. An emphasis will be given to the putative role of IRS-1 and/or-2 genetic variant(s) and serine phosphorylation in precipitating insulin resistance. Insulin resistance is at the crossroads of the cardiometabolic syndrome Insulin resistance is a disorder characterized by the improper utilization of glucose by the cells. This is because of an existing and/or acquired impairment of the cell's ability to respond to exogenous or endogenous insulin. This, in turn, results in β-cell compensation failure and excessive blood glucose levels in the midst of hyperinsulinemia. 1 Insulin resistant subjects are predisposed to a cluster of risk factors that increase their risk of having cardiovascular diseases. These risk factors include high blood pressure, obesity, type 2 diabetes, elevated triglycerides, and lowered high density lipoprotein cholesterol (HDL-C). 1 Alarmingly, over one third of Canadian adults have insulin resistance, 2 and about half of salt-sensitive subjects are insulin resistant. 3 These elevated numbers of insulin resistant cases reflect the enormous economic burden that comes from the treatment modalities of several comorbidities per patient. The molecular mechanism of insulin resistance in hyperten-sion, particularly in salt-sensitive hyperten-sion, is not fully characterized. Insulin resistance might lead to hypertension because of diminished insulin-induced vasodilation and the imbalance between its pressor and depres-sor effects. 1,4,5 In hypertension, there is resistance to the actions of insulin on glucose uptake, but no resistance to the renal and sympathetic actions of insulin. 6-9 These secondary actions of insulin form the basis of the insulin hypothesis of hypertension. This hypothesis proposes that the compensatory hyperinsulinemia that occurs with insulin resistance increases sodium reabsorption and sympathetic activity, which combine to cause an increased vascular resistance and an elevated arterial pressure. 6,10 Owing to the fact that insulin resistance in Dahl salt-sensitive (S) rats precedes salt-sensitive hypertension in this model, we directed our attention to highlighting the putative role of insulin receptor substrates 1 and 2 (IRS-1 and-2) genetic variants in the pathogenesis of insulin resistance in Dahl S rats. Insulin resistance in Dahl S rats Dahl S rats represent an ideal model of insulin resistance syndrome because of its genetically predetermined insulin resistance, 11,12 hypertriglyceridemia, abdominal obesity, and salt-sensitive hypertension. 11 Regarding insulin concentrations, Dahl rats in general have higher values for insulin concentration than control Sprague Dawley rats implying their increased genetic susceptibility to insulin resistance. 11 Additionally, Dahl S rats have an increased serum insulin response to an oral glucose load independent of different salt intakes compared to Dahl salt-resistant (R) rats. 13 Regarding insulin sensitivity, Dahl S rats have decreased sensitivity to insulin, 14 as evidenced by a decreased insulin-stimulated glucose uptake by skeletal muscles obtained from Dahl S vs. Dahl salt-resistant (R) rats. 14 Regarding insulin receptors distribution, number, and affinity, they were all comparable in skeletal muscle and kidney of Dahl S and-R rats, 15 with no change in binding parameters in either group on high or low salt chow. 15 Hepatic, muscular, and renal insulin receptor mRNA levels were comparable in Dahl S and-R rats fed either low or high salt chow. 15 Regarding the impact of salt diet, Dahl S vs.-R rats had significant insulin resistance on high salt diet (8% NaCl) for four weeks vs. normal salt diet. 14 Dahl S rats insulin resistance on a high salt diet was characterized by an activation of the early steps in insulin signaling. 14 On the other hand, salt retention was significantly greater at weeks 1 and 2 in insulin-infused vs. saline-infused Dahl S rats receiving 0.3% NaCl vs. Dahl R rats, where insulin did not influence sodium retention, mean arterial pressure, or plasma epinephrine. 16 In conclusion, genetic background and excessive sodium intake are key factors contributing to the development of insulin resistance and salt sensitive hyperten-sion in Dahl S rats. The decreased sensitivity to insulin in this model may involve a post-receptor defect possibly a genetic variant(s) in the IRS-1 and/or IRS-2 that contribute to their susceptibility to insulin resistance. 12,17 Insulin receptor substrates-1 and-2 Variations in candidate genes encoding IRS-1 and-2 proteins involved in the insulin signaling pathway may be implicated in insulin resistance. Insulin actions in skeletal muscles, liver, kidney, fat, and brain result in increased renal sodium retention, modulation of transmembrane cation transport, induction of growth promoting effects of vascular smooth muscle cells, and vascular hyperreac-tivity. 18 The insulin signal transduction pathway is initiated when insulin binds to a high-affinity heterotetrameric transmembrane protein receptor that is present in all mammalian cells. 4,18 The insulin-receptor complex then triggers tyrosine phosphorylation of second